RESUMO
Syphilis is a sexually transmitted disease caused by the spirochaete Treponema pallidum. Patients with untreated syphilis can develop meningovascular syphilis at any stage of the disease. This is a case report of a 44-year-old man displaying two instances of acute vertigo and lateralized paraesthesia. MRI showed infarctions in the left thalamus and capsula interna. Subsequent investigations including cerebral spinal fluid analysis revealed a diagnosis of neurosyphilis. The patient was treated intravenously with benzylpenicillin and ceftriaxone with complete clinical remission.
Assuntos
Antibacterianos , Ceftriaxona , Neurossífilis , Penicilina G , Humanos , Masculino , Adulto , Neurossífilis/complicações , Neurossífilis/tratamento farmacológico , Neurossífilis/diagnóstico , Penicilina G/uso terapêutico , Penicilina G/administração & dosagem , Antibacterianos/uso terapêutico , Antibacterianos/administração & dosagem , Ceftriaxona/uso terapêutico , Ceftriaxona/administração & dosagem , Imageamento por Ressonância Magnética , AVC Isquêmico/diagnóstico por imagem , AVC Isquêmico/tratamento farmacológico , AVC Isquêmico/etiologiaRESUMO
BACKGROUND: The increased resistance rate of Salmonella to third-generation cephalosporins represented by ceftriaxone (CRO) may result in the failure of the empirical use of third-generation cephalosporins for the treatment of Salmonella infection in children. The present study was conducted to evaluate a novel method for the rapid detection of CRO-resistant Salmonella (CRS). METHODS: We introduced the concept of the ratio of optical density (ROD) with and without CRO and combined it with matrix-assisted laser desorption-ionization time-of-flight mass spectrometry (MALDI-TOF MS) to establish a new protocol for the rapid detection of CRS. RESULTS: The optimal incubation time and CRO concentration determined by the model strain test were 2 h and 8 µg/ml, respectively. We then conducted confirmatory tests on 120 clinical strains. According to the receiver operating characteristic curve analysis, the ROD cutoff value for distinguishing CRS and non-CRS strains was 0.818 [area under the curve: 1.000; 95% confidence interval: 0.970-1.000; sensitivity: 100.00%; specificity: 100%; P < 10- 3]. CONCLUSIONS: In conclusion, the protocol for the combined ROD and MALDI-TOF MS represents a rapid, accurate, and economical method for the detection of CRS.
Assuntos
Antibacterianos , Ceftriaxona , Testes de Sensibilidade Microbiana , Infecções por Salmonella , Salmonella , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz/métodos , Ceftriaxona/farmacologia , Humanos , Antibacterianos/farmacologia , Salmonella/efeitos dos fármacos , Infecções por Salmonella/microbiologia , Testes de Sensibilidade Microbiana/métodos , Farmacorresistência Bacteriana , Sensibilidade e Especificidade , Curva ROCRESUMO
The increase in the resistance of mutant strains of Neisseria gonorrhoeae to the antibiotic ceftriaxone is pronounced in the decrease in the second-order acylation rate constant, k2/KS, by penicillin-binding protein 2 (PBP2). These changes can be caused by both the decrease in the acylation rate constant, k2, and the weakening of the binding affinity, i.e., an increase in the substrate constant, KS. A501X mutations in PBP2 affect second-order acylation rate constants. The PBP2A501V variant exhibits a higher k2/KS value, whereas for PBP2A501R and PBP2A501P variants, these values are lower. We performed molecular dynamic simulations with both classical and QM/MM potentials to model both acylation energy profiles and conformational dynamics of four PBP2 variants to explain the origin of k2/KS changes. The acylation reaction occurs in two elementary steps, specifically, a nucleophilic attack by the oxygen atom of the Ser310 residue and C-N bond cleavage in the ß-lactam ring accompanied by the elimination of the leaving group of ceftriaxone. The energy barrier of the first step increases for PBP2 variants with a decrease in the observed k2/KS value. Submicrosecond classic molecular dynamic trajectories with subsequent cluster analysis reveal that the conformation of the ß3-ß4 loop switches from open to closed and its flexibility decreases for PBP2 variants with a lower k2/KS value. Thus, the experimentally observed decrease in the k2/KS in A501X variants of PBP2 occurs due to both the decrease in the acylation rate constant, k2, and the increase in KS.
Assuntos
Ceftriaxona , Simulação de Dinâmica Molecular , Neisseria gonorrhoeae , Proteínas de Ligação às Penicilinas , Ceftriaxona/farmacologia , Neisseria gonorrhoeae/genética , Neisseria gonorrhoeae/efeitos dos fármacos , Neisseria gonorrhoeae/metabolismo , Proteínas de Ligação às Penicilinas/genética , Proteínas de Ligação às Penicilinas/química , Proteínas de Ligação às Penicilinas/metabolismo , Antibacterianos/farmacologia , Mutação , Farmacorresistência Bacteriana/genética , Acilação , Proteínas de Bactérias/genética , Proteínas de Bactérias/metabolismo , Proteínas de Bactérias/química , D-Ala-D-Ala Carboxipeptidase Tipo SerinaRESUMO
Sortase-assembled pili contribute to virulence in many Gram-positive bacteria. In Enterococcus faecalis, the endocarditis and biofilm-associated pilus (Ebp) is polymerized on the membrane by sortase C (SrtC) and attached to the cell wall by sortase A (SrtA). In the absence of SrtA, polymerized pili remain anchored to the membrane (i.e. off-pathway). Here we show that the high temperature requirement A (HtrA) bifunctional chaperone/protease of E. faecalis is a quality control system that clears aberrant off-pathway pili from the cell membrane. In the absence of HtrA and SrtA, accumulation of membrane-bound pili leads to cell envelope stress and partially induces the regulon of the ceftriaxone resistance-associated CroRS two-component system, which in turn causes hyper-piliation and cell morphology alterations. Inactivation of croR in the OG1RF ΔsrtAΔhtrA background partially restores the observed defects of the ΔsrtAΔhtrA strain, supporting a role for CroRS in the response to membrane perturbations. Moreover, absence of SrtA and HtrA decreases basal resistance of E. faecalis against cephalosporins and daptomycin. The link between HtrA, pilus biogenesis and the CroRS two-component system provides new insights into the E. faecalis response to endogenous membrane perturbations.
Assuntos
Aminoaciltransferases , Proteínas de Bactérias , Biofilmes , Cisteína Endopeptidases , Enterococcus faecalis , Fímbrias Bacterianas , Chaperonas Moleculares , Fímbrias Bacterianas/genética , Fímbrias Bacterianas/metabolismo , Aminoaciltransferases/genética , Aminoaciltransferases/metabolismo , Enterococcus faecalis/genética , Cisteína Endopeptidases/genética , Cisteína Endopeptidases/metabolismo , Proteínas de Bactérias/genética , Proteínas de Bactérias/metabolismo , Chaperonas Moleculares/genética , Chaperonas Moleculares/metabolismo , Biofilmes/crescimento & desenvolvimento , Membrana Celular/metabolismo , Regulação Bacteriana da Expressão Gênica , Virulência/genética , Antibacterianos/farmacologia , Ceftriaxona/farmacologiaRESUMO
SummaryWe describe a case of culture-negative infective endocarditis due to Neisseria gonorrhoeae, where the application of metagenomics shotgun sequencing in blood played a pivotal role in elucidating the underlying aetiology, guiding targeted therapy and ultimately resulting in the patient's complete recovery. Beyond its immediate clinical impact, prompt treatment bears significant implications for public health. The utilisation of molecular testing emerges as a valuable strategy to enhance diagnostic accuracy, particularly in cases involving fastidious organisms that are infrequently associated with infective endocarditis.
Assuntos
Antibacterianos , Endocardite Bacteriana , Gonorreia , Neisseria gonorrhoeae , Valva Tricúspide , Humanos , Gonorreia/diagnóstico , Gonorreia/tratamento farmacológico , Gonorreia/complicações , Neisseria gonorrhoeae/isolamento & purificação , Endocardite Bacteriana/diagnóstico , Endocardite Bacteriana/microbiologia , Endocardite Bacteriana/tratamento farmacológico , Masculino , Valva Tricúspide/microbiologia , Antibacterianos/uso terapêutico , Ceftriaxona/uso terapêutico , Adulto , EcocardiografiaRESUMO
Ceftriaxone-resistant Neisseria gonorrhoeae FC428-like strains have disseminated across the Asia-Pacific region, with a continuous rise in prevalence during 2015-2022. To mitigate the effect of these strains, we advocate for enhanced molecular diagnostics, expanded surveillance networks, and a regionally coordinated effort to combat the global spread of FC428-like strains.
Assuntos
Antibacterianos , Ceftriaxona , Farmacorresistência Bacteriana , Gonorreia , Neisseria gonorrhoeae , Neisseria gonorrhoeae/efeitos dos fármacos , Neisseria gonorrhoeae/genética , Ceftriaxona/farmacologia , Humanos , Gonorreia/microbiologia , Gonorreia/epidemiologia , Gonorreia/tratamento farmacológico , Ásia/epidemiologia , Antibacterianos/farmacologia , Testes de Sensibilidade Microbiana , Prevalência , História do Século XXIRESUMO
Background Gonorrhoea notifications have increased substantially in Australia over the past decade. Neisseria gonorrhoeae is already highly resistant to several antibiotics and so, alternatives to first-line treatment are generally strongly discouraged. The penicillin allergy label (AL) on patient medical records has previously been shown to influence prescribing practices, to the detriment of best-practice management and antimicrobial stewardship. This study aimed to understand how the penicillin AL influences antibiotic selection for gonorrhoea treatment at Canberra Sexual Health Centre. Methods A retrospective chart audit of gonorrhoea cases treated at Canberra Sexual Health Centre between January 2020 and October 2023 (n =619 patients, n =728 cases). Antibiotic selection was assessed according to penicillin AL status. Ceftriaxone selection was assessed according to penicillin allergy severity reported in the medical records and as determined using a validated antibiotic allergy assessment tool. Results Cases with a penicillin AL were more likely to receive antibiotics other than ceftriaxone (n =7/41, 17.1%) than cases without the label (n =8/687, 1.2%, P n =28/41, 68.3%) to apply the assessment tool. Those reported as low-severity in the records were more likely to receive ceftriaxone (n =21/22, 95.5%) than those reported as moderate-high (n =7/11, 63.6%) or unreported (n =6/8, 0.75%). Conclusions Treatment of gonorrhoea in outpatient settings requires an understanding of penicillin allergy, and the ability to quickly and accurately identify penicillin-AL patients who can safely tolerate ceftriaxone. Institutionally endorsed penicillin allergy de-labelling protocols and access to easy-to-navigate prescribing advice within national sexually transmitted infection management guidelines would support this.
Assuntos
Antibacterianos , Ceftriaxona , Hipersensibilidade a Drogas , Gonorreia , Penicilinas , Humanos , Gonorreia/tratamento farmacológico , Ceftriaxona/uso terapêutico , Estudos Retrospectivos , Antibacterianos/uso terapêutico , Penicilinas/uso terapêutico , Penicilinas/efeitos adversos , Feminino , Masculino , Adulto , Neisseria gonorrhoeae , Austrália , Prontuários Médicos , Padrões de Prática Médica/estatística & dados numéricos , Pessoa de Meia-Idade , Rotulagem de MedicamentosRESUMO
BACKGROUND: The indiscriminate use of antibiotics has accelerated antimicrobial resistance (AMR) in Neisseria gonorrhoeae (NG), emphasising the need to follow treatment guidelines. This study aimed to assess the rate of adherence to standard treatment among patients with gonorrhoea and identify influencing factors. METHODS: A survey was conducted in Guangdong province, China, involving uncomplicated gonorrhoea cases registered in the Chinese Information System for Disease Control and Prevention. Data on demographic characteristics and medical information were collected to determine the standard treatment rate, defined as the proportion of patients receiving treatment according to national guidelines (ie, a single dose of ceftriaxone 250 mg, spectinomycin 2 g, cefotaxime 1 g or other third-generation cephalosporins). Medication choices were documented. χ² tests and multilevel logistic regression were used to analyse factors associated with standard treatment. RESULTS: The survey included 2424 patients with gonorrhoea from 59 hospitals. The standard treatment rate was 30.7% (743/2424), with 36.2% for females and 29.6% for males. Common reasons for substandard treatment included the use of non-guideline medications (42.3%, 710/1681) and incorrect dosing (36.2%, 605/1681). Factors associated with the standard treatment rate included gender, address, educational level, department, physicians' training, number of diagnosed gonorrhoea cases and hospital level. CONCLUSION: The standard treatment rate for gonorrhoea in Guangdong province, China, is below expectations. Comprehensive measures, such as establishing a goal-directed monitoring system and implementing promotional activities, are needed to improve adherence to treatment guidelines.
Assuntos
Antibacterianos , Gonorreia , Fidelidade a Diretrizes , Humanos , Gonorreia/tratamento farmacológico , China , Masculino , Feminino , Estudos Transversais , Adulto , Fidelidade a Diretrizes/estatística & dados numéricos , Antibacterianos/uso terapêutico , Antibacterianos/administração & dosagem , Neisseria gonorrhoeae/efeitos dos fármacos , Adulto Jovem , Pessoa de Meia-Idade , Adolescente , Ceftriaxona/uso terapêutico , Modelos LogísticosRESUMO
Lyme neuroborreliosis is a rare zoonosis which can be difficult to diagnose, in particular in low endemic areas. We here report the case of a 35-year-old man presenting with disabling back pain preceded by facial monoplegia, which was wrongly treated as Bell's palsy (paralysis a frigore) and then as post-traumatic lumbosciatica. The onset of facial diplegia allowed for a definitive diagnosis. The patient was treated with ceftriaxone and symptoms gradually improved.
Assuntos
Antibacterianos , Paralisia de Bell , Ceftriaxona , Paralisia Facial , Neuroborreliose de Lyme , Humanos , Masculino , Adulto , Paralisia Facial/etiologia , Paralisia Facial/diagnóstico , Antibacterianos/administração & dosagem , Ceftriaxona/administração & dosagem , Neuroborreliose de Lyme/diagnóstico , Neuroborreliose de Lyme/complicações , Neuroborreliose de Lyme/tratamento farmacológico , Paralisia de Bell/diagnóstico , Paralisia de Bell/etiologia , Dor nas Costas/etiologia , Erros de Diagnóstico , Doença de Lyme/diagnóstico , Doença de Lyme/complicações , Doença de Lyme/tratamento farmacológico , Dor Lombar/etiologiaRESUMO
We report a severe case of a 25-year-old girl presented with complaints of weakness, diarrhoea, vomiting, pain in abdomen and hypotension at Infectious Diseases and Clinical Immunology Research Center. From history on 25 February till 29 February she was in India and on 1 march this problem started with watery diarrhoea followed by vomiting. She ate pizza with mushroom following which her condition worsened. Stool culture revealed salmonella nontyphi (nonthyphodal Salmonella)and this is leading cause for gastroenteritis, bacteremia and affects several other bodily system. Her condition deteriorated due to the development of ARDS (acute respiratory distress syndrome) and for this she was on mechanical ventilation. Vitec machine was performed, which identified Salmonella typhi murium. Our goal is to manage and treat this patient well by early diagnosis. She was given ceftriaxone, iv fluids and symptomatic treatment but due to resistance meropenem was started and the patient's condition improved. From serology there was no evidence of immunocompromised state so being a severe case of immunocompetent patient this case reflects the importance of timely diagnosis and management together with food safety practices in population. On follow up she was stable and discharged after 3 weeks. Future research studies need to be continued regarding newer strains, effective treatment strategies and diagnostics to prevent morbidity and mortality.
Assuntos
Infecções por Salmonella , Adulto , Feminino , Humanos , Antibacterianos/uso terapêutico , Ceftriaxona/uso terapêutico , Diarreia/microbiologia , Meropeném/uso terapêutico , Insuficiência de Múltiplos Órgãos/microbiologia , Insuficiência de Múltiplos Órgãos/etiologia , Síndrome do Desconforto Respiratório/microbiologia , Síndrome do Desconforto Respiratório/etiologia , Infecções por Salmonella/diagnóstico , Infecções por Salmonella/tratamento farmacológico , Infecções por Salmonella/microbiologia , Infecções por Salmonella/complicações , Salmonella typhimurium/isolamento & purificaçãoRESUMO
Ceftriaxone (CTRX) is a commonly used cephalosporin antibiotic. It is suggested that monitoring plasma/serum concentrations is helpful for its safe use. This study aimed to develop and validate an analytical method for measuring CTRX concentrations in human serum according to International Conference on Harmonization guideline M10. Ten microliters of serum sample was purified using a salting-out assisted liquid-liquid extraction procedure with magnesium sulfate. The upper layer was then diluted threefold and analyzed using a liquid chromatography-tandem mass spectrometry-based method with a total run time of 12 min. The linear calibration curve was obtained over the concentration range 5-500 µg/ml. The within-run accuracy varied from 0.2 to 6.5%, and the precision was ≤8.0%. The between-run accuracy and precision ranged from 0.7% to 5.6% and ≤6.4%, respectively. Significant carryover was resolved by injecting four blanks after high-concentration CTRX samples. The recovery rates from spiked serum at low and high concentrations were 44.4 and 43.4%, respectively. Other factors, including selectivity, matrix effects, stability, dilution integrity and reinjection reproducibility also met the acceptance criteria. Serum concentrations in 14 samples obtained from two participants receiving 2 g/day of CTRX were successfully determined using this method.
Assuntos
Ceftriaxona , Extração Líquido-Líquido , Espectrometria de Massas em Tandem , Humanos , Extração Líquido-Líquido/métodos , Ceftriaxona/sangue , Reprodutibilidade dos Testes , Espectrometria de Massas em Tandem/métodos , Modelos Lineares , Limite de Detecção , Cromatografia Líquida/métodosRESUMO
Objective: This study aims to examine the frequency of Salmonella Paratyphi found in blood cultures and evaluate the antibiotic susceptibility pattern of Salmonella isolates to different antibiotics. Additionally, the study aims to assess the paradigm shift in the trend of enteric fever caused by Salmonella Typhi (S. Typhi) to Salmonella Paratyphi(S. Paratyphi) . Study Design: Retrospective study. Participant: The study enrolled patients aged 12 years and above diagnosed with enteric fever (positive blood culture) and admitted to Peelamedu Samanaidu Govindasamy Naidu (PSG) Hospital. Interventions: The study analyzed demographic and antibiotic susceptibility profiles of Salmonella isolates collected from 106 enteric fever patients in the hospital between 2010 and 2022. The susceptibility profiles of Salmonella isolates to multiple antibiotics were assessed. Results: There were 106 participants, and 95 (89.62%) of them had enteric fever linked to Salmonella Typhi, while only 11 (10.38%) had enteric fever linked to Salmonella Paratyphi A. From 2010 to 2022, the study discovered a general decline in the prevalence of enteric fever caused by Salmonella species. But between 2014 and 2022, the incidence of enteric fever linked to S. Typhi rapidly increased. Azithromycin (100% , n = 106) and ceftriaxone (99% , n = 105) were highly effective against the Salmonella isolates, whereas nalidixic acid was resisted by 3 isolates (4.72%, n = 3). Conclusion: The study observed a higher incidence of Salmonella Typhi in comparison to Paratyphi A and a greater susceptibility of males to enteric fever. Funding: None declared.
Assuntos
Antibacterianos , Testes de Sensibilidade Microbiana , Salmonella paratyphi A , Salmonella typhi , Febre Tifoide , Humanos , Masculino , Feminino , Antibacterianos/farmacologia , Antibacterianos/uso terapêutico , Febre Tifoide/epidemiologia , Febre Tifoide/microbiologia , Febre Tifoide/tratamento farmacológico , Estudos Retrospectivos , Salmonella typhi/efeitos dos fármacos , Salmonella typhi/isolamento & purificação , Salmonella paratyphi A/efeitos dos fármacos , Salmonella paratyphi A/isolamento & purificação , Adulto , Adolescente , Criança , Pessoa de Meia-Idade , Adulto Jovem , Febre Paratifoide/epidemiologia , Febre Paratifoide/microbiologia , Febre Paratifoide/tratamento farmacológico , Incidência , Farmacorresistência Bacteriana , Azitromicina/uso terapêutico , Azitromicina/farmacologia , Ceftriaxona/uso terapêutico , Ceftriaxona/farmacologia , Idoso , PrevalênciaRESUMO
BACKGROUND AND OBJECTIVES: There were 82.4 million new gonorrhoea cases worldwide in 2020. Dual treatment with ceftriaxone or cefixime and azithromycin or doxycycline is currently recommended for gonorrhoea in Indonesia. However, reduced susceptibility and resistance to cephalosporins and azithromycin are increasing. We evaluated the susceptibility pattern of Neisseria gonorrhoeae to cefixime, ceftriaxone, azithromycin and doxycycline. METHOD: N. gonorrhoeae isolates were obtained from 19 male participants with clinically and laboratory-confirmed gonorrhoea. Antibiotic susceptibility testing was conducted by disc diffusion and interpreted according to Clinical and Laboratory Standards Institute and Centers for Disease Control and Prevention criteria. RESULTS: Reduced susceptibility or resistance was observed against doxycycline in 19 isolates (100%), cefixime in six (31.6%), ceftriaxone in three (15.8%) and azithromycin in zero (0%) isolates. DISCUSSION: A dual treatment regimen with ceftriaxone and azithromycin can still be recommended as first-line therapy for gonorrhoea in Indonesia. Antibiotic susceptibility surveillance of N. gonorrhoeae should be routinely conducted.
Assuntos
Antibacterianos , Azitromicina , Ceftriaxona , Doxiciclina , Gonorreia , Testes de Sensibilidade Microbiana , Neisseria gonorrhoeae , Humanos , Indonésia , Neisseria gonorrhoeae/efeitos dos fármacos , Antibacterianos/uso terapêutico , Antibacterianos/farmacologia , Gonorreia/tratamento farmacológico , Masculino , Testes de Sensibilidade Microbiana/métodos , Azitromicina/uso terapêutico , Doxiciclina/uso terapêutico , Ceftriaxona/uso terapêutico , Ceftriaxona/farmacologia , Adulto , Cefixima/uso terapêutico , Cefixima/farmacologia , Atenção Primária à Saúde/estatística & dados numéricos , Farmacorresistência Bacteriana/efeitos dos fármacos , Quimioterapia Combinada/métodosRESUMO
Acute pyogenic meningitis is a medical emergency. Bacteria are the major causative agents of pyogenic meningitis with Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis being the most common. Here, we describe a case of bacterial meningoencephalitis caused by Streptococcus porcinus. To our knowledge this is the first case described in literature. The patient was treated with ceftriaxone and supportive treatment.
Assuntos
Antibacterianos , Ceftriaxona , Meningoencefalite , Infecções Estreptocócicas , Streptococcus , Humanos , Meningoencefalite/microbiologia , Meningoencefalite/tratamento farmacológico , Meningoencefalite/diagnóstico , Antibacterianos/uso terapêutico , Infecções Estreptocócicas/microbiologia , Infecções Estreptocócicas/tratamento farmacológico , Infecções Estreptocócicas/diagnóstico , Ceftriaxona/uso terapêutico , Streptococcus/isolamento & purificação , Streptococcus/classificação , Masculino , Resultado do Tratamento , Meningites Bacterianas/microbiologia , Meningites Bacterianas/tratamento farmacológico , Meningites Bacterianas/diagnósticoRESUMO
OBJECTIVES: To determine whether concomitant use of ceftriaxone and oral or intravenous lansoprazole increases the risk of ventricular arrhythmia and cardiac arrest in the real-world setting in Japan. METHODS: The data analyzed were obtained from the JMDC hospital-based administrative claims database for the period April 2014 to August 2022. Patients who received a proton pump inhibitor (PPI) while receiving ceftriaxone or sulbactam/ampicillin were identified. The frequency of ventricular arrhythmia and cardiac arrest was analyzed according to whether oral or intravenous PPI was concomitant with ceftriaxone or sulbactam/ampicillin. Estimates of the incidence of ventricular arrhythmia and cardiac arrest were then compared among the groups, using the Fine-Gray competing risk regression model. RESULTS: The results showed that the risk of ventricular arrhythmia and cardiac arrest was significantly higher with concomitant ceftriaxone and oral lansoprazole (hazard ratio 2.92, 95% confidence interval 1.99-4.29, P < 0.01) or intravenous lansoprazole (hazard ratio 4.57, 95% confidence interval 1.24-16.80, P = 0.02) than with concomitant sulbactam/ampicillin and oral or intravenous lansoprazole. CONCLUSIONS: Oral and intravenous lansoprazole may increase the risk of ventricular arrhythmia and cardiac arrest in patients who are receiving ceftriaxone.
Assuntos
Arritmias Cardíacas , Ceftriaxona , Parada Cardíaca , Lansoprazol , Inibidores da Bomba de Prótons , Humanos , Lansoprazol/efeitos adversos , Lansoprazol/administração & dosagem , Ceftriaxona/efeitos adversos , Ceftriaxona/administração & dosagem , Parada Cardíaca/induzido quimicamente , Parada Cardíaca/epidemiologia , Masculino , Japão/epidemiologia , Feminino , Idoso , Pessoa de Meia-Idade , Inibidores da Bomba de Prótons/efeitos adversos , Inibidores da Bomba de Prótons/administração & dosagem , Arritmias Cardíacas/induzido quimicamente , Arritmias Cardíacas/epidemiologia , Antibacterianos/efeitos adversos , Antibacterianos/administração & dosagem , Bases de Dados Factuais , Idoso de 80 Anos ou mais , Adulto , Estudos Retrospectivos , Incidência , Administração Oral , Fatores de Risco , Quimioterapia Combinada/efeitos adversos , População do Leste AsiáticoRESUMO
OBJECTIVE: Monitoring the susceptibility patterns of Neisseria gonorrhoeae is essential for the continuing compliance with current treatment recommendations. Puerto Rico conducts susceptibility tests on N. gonorrhoeae; however, trends on antimicrobial resistance in the island have not been reported since the mid 80's. METHODS: We performed a secondary analysis of a national data repository on the antimicrobial susceptibility of N. gonorrhoeae isolates between 2012 and 2017; a period of time when the CDC recommended a single dose of ceftriaxone and azithromycin for the treatment of uncomplicated gonorrhea. Data on susceptibility to eight antibiotics using the standard disk diffusion method was obtained for 30.0% (84/276) of the samples collected from the Sexually Transmitted Disease clinics in Puerto Rico. We also performed patient demographic analyses linked to resistance. RESULTS: Rates of resistance to ceftriaxone and azithromycin were 0% and 4.0% (2/50), respectively. The percentage of isolates resistant to antimicrobials no longer recommended in Puerto Rico, such as tetracycline, ciprofloxacin, and penicillin, was 86.0% (43/50), 76.0% (38/50), and 38.0% (19/50), respectively. Prevalence of resistant N. gonorrhoeae was higher among men who have sex with men, MSM (79%, 37/47). DISCUSSION: Lack of resistance to ceftriaxone and slow emergence of azithromycin resistance was identified from 2012-2017. It is imperative to continue the surveillance for emerging patterns of resistance, especially for ceftriaxone, as it is part of the current treatment guidelines. Therefore, protocols for culture based surveillance, including sample transport and processing, should be strengthened to ensure quality assured epidemiology of gonococcal resistance in Puerto Rico.
Assuntos
Antibacterianos , Farmacorresistência Bacteriana , Gonorreia , Testes de Sensibilidade Microbiana , Neisseria gonorrhoeae , Porto Rico , Neisseria gonorrhoeae/efeitos dos fármacos , Neisseria gonorrhoeae/isolamento & purificação , Humanos , Masculino , Gonorreia/tratamento farmacológico , Gonorreia/microbiologia , Gonorreia/epidemiologia , Feminino , Antibacterianos/farmacologia , Antibacterianos/administração & dosagem , Adulto , Adulto Jovem , Azitromicina/farmacologia , Azitromicina/administração & dosagem , Ceftriaxona/farmacologia , Adolescente , Pessoa de Meia-IdadeRESUMO
Nocardia pyomyositis in immunocompetent patients is a rare occurrence. The diagnosis may be missed or delayed with the risk of progressive infection and suboptimal or inappropriate treatment. We present the case of a 48-year-old immunocompetent firefighter diagnosed with pyomyositis caused by Nocardia brasiliensis acquired by direct skin inoculation from gardening activity. The patient developed a painful swelling on his right forearm that rapidly progressed proximally and deeper into the underlying muscle layer. Ultrasound imaging of his right forearm showed a 7-mm subcutaneous fluid collection with surrounding edema. Microbiologic analysis of the draining pus was confirmed to be N brasiliensis by Matrix-Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-TOF) Mass Spectrometry. After incision and drainage deep to the muscle layer to evacuate the abscess and a few ineffective antibiotic options, the patient was treated with intravenous ceftriaxone and oral linezolid for 6 weeks. He was then de-escalated to oral moxifloxacin for an additional 4 months to complete a total antibiotic treatment duration of 6 months. The wound healed satisfactorily and was completely closed by the fourth month of antibiotic therapy. Six months after discontinuation of antibiotics, the patient continued to do well with complete resolution of the infection. In this article, we discussed the risk factors for Nocardia in immunocompetent settings, the occupational risks for Nocardia in our index patient, and the challenges encountered with diagnosis and treatment. Nocardia should be included in the differential diagnosis of cutaneous infections, particularly if there is no improvement of "cellulitis" with traditional antimicrobial regimens and the infection extends into the deeper muscle tissues.
Assuntos
Antibacterianos , Jardinagem , Imunocompetência , Nocardiose , Nocardia , Piomiosite , Humanos , Masculino , Pessoa de Meia-Idade , Nocardiose/diagnóstico , Nocardiose/tratamento farmacológico , Nocardia/isolamento & purificação , Antibacterianos/uso terapêutico , Piomiosite/tratamento farmacológico , Piomiosite/diagnóstico , Piomiosite/microbiologia , Ceftriaxona/uso terapêutico , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz , Drenagem , Moxifloxacina/uso terapêutico , Moxifloxacina/administração & dosagem , Linezolida/uso terapêuticoRESUMO
Iliopsoas abscess is an infrequent condition characterized by the collection of pus in the iliopsoas compartment. The prevalence of the disease has been increasing in recent years with the emergence of various comorbidities and risk factors. The availability of newer imaging modalities has also improved the detection of new cases. Salmonellosis is an uncommon etiology in iliopsoas abscess and sacroiliitis. Most cases reported in the literature are associated with Staphylococcus aureus, Streptococci species, and Escherichia coli. Diabetes, hematological malignancies, HIV, and other immunocompromised states are important comorbidities/risk factors for iliopsoas abscess. We report a case of an 18-year-old male who presented with a history of fever and right hip pain for 10 days. Radioimaging revealed right sacroiliitis and iliopsoas abscess. Blood culture revealed pan-sensitive Salmonella typhi. After the prolonged course of antibiotics (intravenous ceftriaxone followed by oral levofloxacin), the patient improved with no further relapse in symptoms. Salmonella typhi should be an important differential of iliopsoas abscess in endemic regions after ruling out the common etiology such as S. aureus and Mycobacterium tuberculosis.
Assuntos
Antibacterianos , Ceftriaxona , Abscesso do Psoas , Sacroileíte , Salmonella typhi , Humanos , Masculino , Abscesso do Psoas/microbiologia , Abscesso do Psoas/tratamento farmacológico , Abscesso do Psoas/diagnóstico por imagem , Adolescente , Sacroileíte/microbiologia , Sacroileíte/tratamento farmacológico , Sacroileíte/diagnóstico por imagem , Salmonella typhi/isolamento & purificação , Antibacterianos/uso terapêutico , Ceftriaxona/uso terapêutico , Febre Tifoide/tratamento farmacológico , Febre Tifoide/complicações , Febre Tifoide/diagnóstico , Febre Tifoide/microbiologia , Levofloxacino/uso terapêutico , ImunocompetênciaRESUMO
BACKGROUND: This study tested the hypothesis that combined ceftriaxone (Cef) and human umbilical cord-derived mesenchymal stem cells (HUCDMSCs) was better than either therapy for alleviating acute septic arthritis (ASA). METHODS AND RESULTS: Adult-male C57BL/6 mice were categorized into control group (Clt), group A (ASA only), group B [ASAâ +â Cef (5 mg/kg, IM per day, at days 2 to 16 after ASA induction)], group C [ASAâ +â HUCDMSCs (5â ×â 105 per mice at days 2, 3, 4 after ASA induction)], and group D (ASAâ +â Cefâ +â HUCDMSCs). Animals were euthanized by day 28. The result demonstrated that the body weight was significantly lower, whereas the ratio of kidney or spleen weight to WB, circulatory WBC count, bacterial colony-formation-unit from circulatory/kidney extraction were significantly higher in group A than in other groups (all Pâ <â .001). The proinflammatory cytokines (IL-6/TNF-α) of knee joint fluid were lowest in Clt and significantly and progressively reduced from groups A to D, whereas the circulatory levels of these 2 parameters at the time points of days 3/7/28 exhibited an identical pattern as knee joint fluid among the groups (all P-valueâ <â .0001). The scores of vertebral-bone destructions/inflamed synovium were lowest in Clt, highest in group A, significantly higher in group C than in groups B/D, and significantly higher in group C than in group D (all Pâ <â .0001). CONCLUSION: Combined antibiotics and Cef and HUCDMSCs was superior to just one therapy for suppressing circulatory and tissue levels of inflammation and knee joint destruction in ASA.
Assuntos
Artrite Infecciosa , Ceftriaxona , Transplante de Células-Tronco Mesenquimais , Células-Tronco Mesenquimais , Camundongos Endogâmicos C57BL , Animais , Ceftriaxona/farmacologia , Artrite Infecciosa/tratamento farmacológico , Artrite Infecciosa/terapia , Transplante de Células-Tronco Mesenquimais/métodos , Masculino , Células-Tronco Mesenquimais/metabolismo , Camundongos , Humanos , Antibacterianos/farmacologiaRESUMO
BACKGROUND: A small proportion of Escherichia coli and Klebsiella pneumoniae demonstrate in vitro non-susceptibility to piperacillin/tazobactam but retain susceptibility to ceftriaxone. Uncertainty remains regarding how best to treat these isolates. OBJECTIVES: We sought to compare clinical outcomes between patients with piperacillin/tazobactam-non-susceptible but ceftriaxone-susceptible E. coli or K. pneumoniae bloodstream infection receiving definitive therapy with ceftriaxone versus an alternative effective antibiotic. METHODS: We retrospectively identified patients with a positive blood culture for piperacillin/tazobactam-non-susceptible but ceftriaxone-susceptible E. coli or K. pneumoniae between 1 January 2013 and 31 December 2022. Patients were divided into one of two definitive treatment groups: ceftriaxone or alternative effective antibiotic. Our primary outcome was a composite of 90â day all-cause mortality, hospital readmission, or recurrence of infection. We used Cox proportional hazards models to compare time with the composite outcome between groups. RESULTS: Sixty-two patients were included in our analysis. Overall, median age was 63â years (IQR 49.5-71.0), the most common source of infection was intra-abdominal (25/62; 40.3%) and the median total duration of therapy was 12.0â days (IQR 9.0-16.8). A total of 9/22 (40.9%) patients in the ceftriaxone treatment group and 18/40 (45.0%) patients in the alternative effective antibiotic group met the composite endpoint. In an adjusted time-to-event analysis, there was no difference in the composite endpoint between groups (HR 0.67, 95% CI 0.30-1.50). The adjusted Bayesian posterior probability that the HR was less than or equal to 1 (i.e. ceftriaxone is as good or better than alternative therapy) was 85%. CONCLUSIONS: These findings suggest that ceftriaxone can be used to effectively treat bloodstream infections with E. coli or K. pneumoniae that are non-susceptible to piperacillin/tazobactam but susceptible to ceftriaxone.